Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses
- 1 May 2023
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (5) , e2315823
Abstract
In 1971, President Richard Nixon signed the National Cancer Act, signifying the beginning of the war on cancer. At that time, cancer was the second leading cause of death in the US. It remains so today with an estimated 606 520 US individuals dying of cancer in 2020.1 As a result, President Joseph Biden launched the Cancer Moonshot with the mission of reducing cancer mortality by at least one-half and improving the experience of individuals living with and surviving cancer.2Keywords
This publication has 31 references indexed in Scilit:
- Economic Burden of Cancer Survivorship Among Adults in the United StatesJournal of Clinical Oncology, 2013
- Racial Differences in Breast Cancer Stage at Diagnosis in the Mammography EraAmerican Journal of Public Health, 2013
- An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case Of CancerHealth Affairs, 2012
- Environmental Health Disparities in HousingAmerican Journal of Public Health, 2011
- An economic evaluation of the war on cancerJournal of Health Economics, 2010
- Socioeconomic Disparities in Health in the United States: What the Patterns Tell UsAmerican Journal of Public Health, 2010
- The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000Forum for Health Economics and Policy, 2010
- Ill health and retirement in Britain: A panel data-based analysisJournal of Health Economics, 2006
- Racial Differences in the Treatment of Early-Stage Lung CancerNew England Journal of Medicine, 1999
- Income and employment effects of health shocks A test case for the German welfare stateJournal of Population Economics, 1999